Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
US Army
Johnson and Johnson
Colorcon
Deloitte
Accenture
Cerilliant
Mallinckrodt

Generated: April 20, 2018

DrugPatentWatch Database Preview

MODRASTANE Drug Profile

« Back to Dashboard

When do Modrastane patents expire, and what generic alternatives are available?

Modrastane is a drug marketed by Bioenvision and is included in one NDA.

The generic ingredient in MODRASTANE is trilostane. There are two drug master file entries for this compound. Additional details are available on the trilostane profile page.
Drug patent expirations by year for MODRASTANE
Synonyms for MODRASTANE
(1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0;{2,8}.0;{6,8}.0;{12,16}]octadec-4-ene-4-carbonitrile
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0?,?.0?,?.0??,??]octadec-4-ene-4-carbonitrile
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-DIHYDROXY-2,16-DIMETHYL-7-OXAPENTACYCLO[9.7.0.0(2),?.0?,?.0(1)(2),(1)?]OCTADEC-4-ENE-4-CARBONITRILE
(4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile
13647-35-3
27107-98-8
28414-46-2
3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile
4.alpha.,5-Epoxy-3,17.beta.-dihydroxy-5.alpha.-androst-2-ene-2-carbonitrile
4.alpha.,5.alpha.-Epoxy-3,17.beta.-dihydroxyandrost-2-ene-2-carebonitrile
42179-EP2270008A1
42179-EP2292617A1
42179-EP2298768A1
42179-EP2311808A1
42179-EP2311829A1
4CA-1281
647T353
AB0008433
AB01274788_02
AB01274788-01
AB2000090
AC-927
AC1LBG6J
AC1LCV8M
AKOS015964043
AKOS032947221
AN-15427
Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4.alpha.,5.alpha.,17.beta.)-
Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4a,5a,17b)-
AOB5601
BC213678
BCP0726000098
C-19989
C12580
CAS-13647-35-3
CC-35370
CHEBI:32260
CHEMBL1200907
CS-1707
CTK8G3608
D01180
D03XOC
DB01108
Desopan
Desopan (TN)
DSSTox_CID_3706
DSSTox_GSID_23706
DSSTox_RID_77157
DTXSID9023706
EN300-122374
EN300-296100
GTPL6850
HY-14281
I14-1247
KB-76443
KS-1414
KVJXBPDAXMEYOA-UHFFFAOYSA-N
L0FPV48Q5R
MCULE-8531625687
MFCD00199295
Modrenal
Modrenal (TN)
MolPort-003-850-727
NCGC00255201-01
NCGC00274061-01
NE46397
PL000251
PubChem13638
Q-201884
s1404
SC-18945
SCHEMBL7517
Tox21_112454
Tox21_112454_1
Tox21_302406
Trilostane
Trilostane (JAN/USAN)
Trilostane [USAN:INN:BAN:JAN]
Trilostane, >=98% (HPLC)
Trilostano
Trilostanum
UNII-L0FPV48Q5R
Vetoryl
Vetoryl (TN)
Vetoryl, Trilostane
VZ34001
WIN 24,540
Win 24540
Win-24540
Z1563146079
ZINC100038546

US Patents and Regulatory Information for MODRASTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bioenvision MODRASTANE trilostane CAPSULE;ORAL 018719-002 Dec 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bioenvision MODRASTANE trilostane CAPSULE;ORAL 018719-001 Dec 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Fish and Richardson
Harvard Business School
Cantor Fitzgerald
Chinese Patent Office
Federal Trade Commission
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.